 Sarah Jolley
Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 11 | 2025 | 827 | 3.240 |
Why?
| | Alcoholism | 6 | 2025 | 807 | 1.550 |
Why?
| | Psychotic Disorders | 5 | 2021 | 170 | 1.470 |
Why?
| | Critical Illness | 8 | 2024 | 811 | 1.470 |
Why?
| | Occupational Therapy | 2 | 2022 | 100 | 1.060 |
Why?
| | Early Ambulation | 2 | 2017 | 24 | 0.970 |
Why?
| | Pneumonia | 4 | 2023 | 639 | 0.970 |
Why?
| | Survivors | 4 | 2025 | 493 | 0.930 |
Why?
| | Patient Admission | 1 | 2025 | 197 | 0.830 |
Why?
| | Physical Therapy Modalities | 3 | 2017 | 308 | 0.820 |
Why?
| | Child Behavior | 2 | 2015 | 248 | 0.790 |
Why?
| | Respiration, Artificial | 3 | 2017 | 645 | 0.750 |
Why?
| | Problem Behavior | 1 | 2023 | 102 | 0.730 |
Why?
| | Mobility Limitation | 2 | 2019 | 61 | 0.730 |
Why?
| | Adolescent Health Services | 1 | 2021 | 71 | 0.690 |
Why?
| | Psychomotor Agitation | 1 | 2020 | 71 | 0.650 |
Why?
| | Adolescent Behavior | 2 | 2015 | 530 | 0.650 |
Why?
| | Aftercare | 2 | 2023 | 208 | 0.600 |
Why?
| | Substance-Related Disorders | 2 | 2025 | 1083 | 0.580 |
Why?
| | Patient Discharge | 3 | 2024 | 897 | 0.570 |
Why?
| | Opioid-Related Disorders | 2 | 2023 | 515 | 0.560 |
Why?
| | Cocaine-Related Disorders | 1 | 2019 | 113 | 0.560 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.540 |
Why?
| | Adult | 25 | 2025 | 37929 | 0.520 |
Why?
| | Mental Health Services | 1 | 2021 | 421 | 0.510 |
Why?
| | Fluid Therapy | 1 | 2017 | 147 | 0.500 |
Why?
| | Venous Thromboembolism | 1 | 2020 | 316 | 0.490 |
Why?
| | Life Support Care | 1 | 2016 | 33 | 0.480 |
Why?
| | Marijuana Use | 1 | 2019 | 206 | 0.470 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2016 | 96 | 0.470 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.470 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.460 |
Why?
| | Bullying | 1 | 2015 | 38 | 0.460 |
Why?
| | Humans | 49 | 2025 | 137585 | 0.460 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2023 | 301 | 0.450 |
Why?
| | HIV Infections | 3 | 2019 | 2836 | 0.450 |
Why?
| | Hospitals, Teaching | 1 | 2015 | 118 | 0.450 |
Why?
| | Neuromuscular Diseases | 1 | 2016 | 132 | 0.430 |
Why?
| | Adolescent Development | 1 | 2015 | 86 | 0.430 |
Why?
| | Middle Aged | 19 | 2025 | 33479 | 0.430 |
Why?
| | Self Concept | 1 | 2015 | 253 | 0.420 |
Why?
| | Crime Victims | 1 | 2015 | 127 | 0.410 |
Why?
| | Clinical Protocols | 1 | 2015 | 271 | 0.410 |
Why?
| | Family Therapy | 1 | 2013 | 65 | 0.400 |
Why?
| | Alcohol Drinking | 2 | 2019 | 828 | 0.400 |
Why?
| | Activities of Daily Living | 3 | 2023 | 413 | 0.400 |
Why?
| | Retrospective Studies | 15 | 2025 | 15657 | 0.390 |
Why?
| | Female | 27 | 2025 | 73304 | 0.380 |
Why?
| | Hospitalization | 8 | 2025 | 2199 | 0.370 |
Why?
| | Male | 25 | 2025 | 67762 | 0.360 |
Why?
| | Louisiana | 2 | 2024 | 29 | 0.350 |
Why?
| | Prevalence | 5 | 2025 | 2734 | 0.350 |
Why?
| | Cognition | 3 | 2023 | 1153 | 0.340 |
Why?
| | Aged | 12 | 2025 | 23961 | 0.330 |
Why?
| | Child Development | 1 | 2015 | 475 | 0.320 |
Why?
| | Motor Activity | 1 | 2015 | 718 | 0.320 |
Why?
| | Referral and Consultation | 1 | 2014 | 786 | 0.290 |
Why?
| | Length of Stay | 3 | 2020 | 1215 | 0.290 |
Why?
| | Cohort Studies | 8 | 2024 | 5742 | 0.290 |
Why?
| | Multicenter Studies as Topic | 3 | 2023 | 310 | 0.280 |
Why?
| | Weight Gain | 1 | 2011 | 519 | 0.270 |
Why?
| | Ethanol | 2 | 2022 | 608 | 0.270 |
Why?
| | Attitude of Health Personnel | 1 | 2014 | 1171 | 0.250 |
Why?
| | Adolescent | 10 | 2025 | 21513 | 0.240 |
Why?
| | Respiratory Insufficiency | 2 | 2023 | 318 | 0.240 |
Why?
| | Colorado | 3 | 2025 | 4565 | 0.230 |
Why?
| | United States | 6 | 2025 | 14841 | 0.230 |
Why?
| | Prospective Studies | 7 | 2023 | 7604 | 0.230 |
Why?
| | Washington | 2 | 2015 | 156 | 0.220 |
Why?
| | Hospital Mortality | 2 | 2025 | 911 | 0.210 |
Why?
| | Hand Strength | 1 | 2024 | 123 | 0.210 |
Why?
| | Multivariate Analysis | 2 | 2019 | 1509 | 0.210 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5472 | 0.200 |
Why?
| | Body Mass Index | 1 | 2011 | 2389 | 0.190 |
Why?
| | Critical Care | 3 | 2024 | 601 | 0.190 |
Why?
| | Telerehabilitation | 1 | 2022 | 37 | 0.190 |
Why?
| | Quality of Life | 4 | 2023 | 2892 | 0.180 |
Why?
| | Child | 5 | 2023 | 21935 | 0.180 |
Why?
| | Naltrexone | 1 | 2022 | 97 | 0.180 |
Why?
| | Central Nervous System Depressants | 1 | 2021 | 85 | 0.180 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2828 | 0.180 |
Why?
| | Risk Factors | 4 | 2024 | 10388 | 0.170 |
Why?
| | Nursing Assessment | 1 | 2020 | 59 | 0.170 |
Why?
| | Longitudinal Studies | 2 | 2025 | 2844 | 0.160 |
Why?
| | School Health Services | 1 | 2023 | 238 | 0.160 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2022 | 238 | 0.160 |
Why?
| | Patient Acceptance of Health Care | 2 | 2025 | 806 | 0.160 |
Why?
| | Schools | 1 | 2023 | 461 | 0.160 |
Why?
| | Mobile Applications | 1 | 2022 | 183 | 0.160 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2021 | 179 | 0.160 |
Why?
| | Exercise | 1 | 2011 | 2057 | 0.160 |
Why?
| | Frailty | 1 | 2022 | 170 | 0.150 |
Why?
| | Tobacco Smoking | 1 | 2018 | 25 | 0.150 |
Why?
| | Pandemics | 3 | 2023 | 1639 | 0.140 |
Why?
| | Decision Making | 1 | 2025 | 900 | 0.140 |
Why?
| | Tobacco Use | 1 | 2018 | 64 | 0.140 |
Why?
| | Emotions | 1 | 2023 | 548 | 0.140 |
Why?
| | Substance Abuse, Intravenous | 1 | 2019 | 115 | 0.140 |
Why?
| | Inpatients | 1 | 2022 | 500 | 0.140 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2019 | 271 | 0.140 |
Why?
| | Tobacco Products | 1 | 2018 | 138 | 0.140 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 104 | 0.130 |
Why?
| | Markov Chains | 1 | 2017 | 126 | 0.130 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2019 | 652 | 0.130 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2019 | 205 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2023 | 1477 | 0.130 |
Why?
| | Community-Acquired Infections | 1 | 2019 | 174 | 0.130 |
Why?
| | Linear Models | 1 | 2019 | 849 | 0.130 |
Why?
| | Curriculum | 1 | 2023 | 992 | 0.130 |
Why?
| | Muscular Diseases | 1 | 2017 | 114 | 0.120 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 39 | 0.120 |
Why?
| | Alcohol-Related Disorders | 1 | 2017 | 122 | 0.120 |
Why?
| | Health Facility Size | 1 | 2015 | 11 | 0.120 |
Why?
| | Homosexuality, Male | 1 | 2016 | 184 | 0.120 |
Why?
| | Biomedical Research | 1 | 2021 | 692 | 0.120 |
Why?
| | Hospitals, Low-Volume | 1 | 2015 | 22 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2023 | 815 | 0.110 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2023 | 847 | 0.110 |
Why?
| | Delivery of Health Care | 1 | 2022 | 951 | 0.110 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 44 | 0.110 |
Why?
| | Internal-External Control | 1 | 2015 | 71 | 0.110 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2019 | 363 | 0.110 |
Why?
| | Comorbidity | 1 | 2019 | 1622 | 0.110 |
Why?
| | Aggression | 1 | 2015 | 202 | 0.100 |
Why?
| | Physical Therapists | 1 | 2014 | 62 | 0.100 |
Why?
| | Pilot Projects | 2 | 2022 | 1710 | 0.100 |
Why?
| | Logistic Models | 2 | 2017 | 2074 | 0.100 |
Why?
| | Conscious Sedation | 1 | 2014 | 92 | 0.100 |
Why?
| | Sex Factors | 1 | 2019 | 2071 | 0.100 |
Why?
| | Telemedicine | 1 | 2022 | 862 | 0.100 |
Why?
| | Tracheostomy | 1 | 2014 | 133 | 0.100 |
Why?
| | Young Adult | 4 | 2025 | 13209 | 0.090 |
Why?
| | Schizophrenic Psychology | 1 | 2012 | 94 | 0.090 |
Why?
| | Nurses | 1 | 2014 | 180 | 0.090 |
Why?
| | Data Collection | 1 | 2014 | 673 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2018 | 1069 | 0.090 |
Why?
| | Psychometrics | 1 | 2015 | 720 | 0.090 |
Why?
| | Surveys and Questionnaires | 2 | 2014 | 5778 | 0.090 |
Why?
| | Attitude to Health | 1 | 2012 | 439 | 0.070 |
Why?
| | Schizophrenia | 1 | 2012 | 439 | 0.070 |
Why?
| | Energy Intake | 1 | 2011 | 485 | 0.070 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 2069 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2017 | 1724 | 0.060 |
Why?
| | Time Factors | 1 | 2017 | 6828 | 0.060 |
Why?
| | Child, Preschool | 1 | 2021 | 11074 | 0.060 |
Why?
| | Physicians | 1 | 2014 | 910 | 0.060 |
Why?
| | Risk Assessment | 1 | 2015 | 3457 | 0.060 |
Why?
| | Observational Studies as Topic | 1 | 2023 | 117 | 0.050 |
Why?
| | Fatigue | 1 | 2023 | 329 | 0.040 |
Why?
| | Cognitive Dysfunction | 1 | 2024 | 383 | 0.040 |
Why?
| | Needs Assessment | 1 | 2021 | 376 | 0.040 |
Why?
| | New Orleans | 1 | 2018 | 14 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2013 | 10811 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2022 | 956 | 0.040 |
Why?
| | Qualitative Research | 1 | 2025 | 1386 | 0.040 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2019 | 127 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 778 | 0.040 |
Why?
| | Age Distribution | 1 | 2018 | 392 | 0.030 |
Why?
| | Sex Distribution | 1 | 2018 | 375 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2022 | 546 | 0.030 |
Why?
| | Tidal Volume | 1 | 2017 | 86 | 0.030 |
Why?
| | Societies, Medical | 1 | 2021 | 820 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2025 | 3556 | 0.030 |
Why?
| | Sputum | 1 | 2019 | 311 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1242 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2025 | 1329 | 0.030 |
Why?
| | Machine Learning | 1 | 2022 | 493 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2024 | 1430 | 0.030 |
Why?
| | Selectins | 1 | 2016 | 8 | 0.030 |
Why?
| | Angiopoietin-1 | 1 | 2016 | 11 | 0.030 |
Why?
| | Angiopoietin-2 | 1 | 2016 | 16 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2016 | 93 | 0.030 |
Why?
| | Anxiety | 1 | 2023 | 1035 | 0.030 |
Why?
| | Urban Population | 1 | 2018 | 479 | 0.030 |
Why?
| | Mental Health | 1 | 2022 | 726 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2757 | 0.030 |
Why?
| | Vaccination | 1 | 2024 | 1381 | 0.030 |
Why?
| | Quality Improvement | 1 | 2021 | 1178 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 233 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2837 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1990 | 68 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2012 | 547 | 0.020 |
Why?
| | Neurofibromatosis 1 | 1 | 1990 | 52 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1316 | 0.020 |
Why?
| | Genetic Markers | 1 | 1990 | 344 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4060 | 0.020 |
Why?
| | DNA | 1 | 1990 | 1459 | 0.010 |
Why?
| | Animals | 1 | 2017 | 36940 | 0.010 |
Why?
| | Genetic Carrier Screening | 1 | 1990 | 28 | 0.010 |
Why?
| | Lod Score | 1 | 1990 | 67 | 0.010 |
Why?
| | DNA Probes | 1 | 1990 | 60 | 0.010 |
Why?
| | Genetic Linkage | 1 | 1990 | 297 | 0.000 |
Why?
| | Pedigree | 1 | 1990 | 514 | 0.000 |
Why?
| | Alleles | 1 | 1990 | 891 | 0.000 |
Why?
|
|
Jolley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|